Immune Health Supplements Market: Segmented By Ingredient type (Vitamins, Mineral, Herbal Botanical extracts, Probiotics, Amino Acids, Omega 3-fatty acids, Others); By Form (Soft Gels/ Capsules, Tablets, powder, liquids and others); By Source type (Plant-Based, Animal-Based); By Distribution Channel (Pharmacies and Drug stores, Hypermarket/Supermarket, Online stores, Specialty stores) and Region – Global Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030
Product Overview
As customers grow more worried about their health, immunity care has become an important element of today's hectic lifestyle. Nutritional supplements are used by today's time-conscious customers, even those who maintain healthy, balanced diets. Consumers all around the globe are feeling the need to strengthen their immune systems to prevent the negative consequences of infectious illnesses. Immune health supplements are essential for managing chronic diseases including diabetes, obesity, constipation, malabsorption, and indigestion. It also aids in the maintenance of a healthy lifestyle, the improvement of appetite and food intake, and the reduction of the danger of vitamin deficiencies and other health problems. Immune health supplements are advised for patients of all ages, including babies, adults, and geriatrics, who are at risk for diabetes, obesity, renal failure, chronic diseases, neurological diseases, and other illnesses.
Market Highlights
Global Immune Health Supplements Market is expected to project a notable CAGR of 6.65% in 2030.
Global Immune Health Supplements Market to surpass USD 30.93 billion by 2030 from USD 16.24 billion in 2020 at a CAGR of 6.65% in the coming years, i.e., 2020-30. The market is estimated to proliferate owing to the increasing awareness related to health matters, wellness trends, and changing routines. In addition, increasing trend of customized products based on health claims is predicted to fuel the growth of the market. Furthermore, the need for immunity-based health supplements is increasing as the population ages, in order to prevent or treat existing illnesses.
Recent highlights in the Global Immune Health Supplements Market
In February 2019, Swisse, Australian health, and wellness company has introduced Vitamin C+Manuka honey chewing tablets. Lemon and acerola cherry extracts are also included in the formula, which helps to boost the immune system.
In April 2020, Glycom, a major provider of Human Milk Oligosaccharides, has been acquired by Royal DSM, a global science-based corporation in nutrition, health, and sustainable living (HMOs). DSM aims to maintain its leadership in the early life nutrition and dietary supplement market with the help of this purchase.
Global Immune Health Supplements Market: Segments
Vitamins and minerals segment to grow with the highest CAGR during 2020-30
Global Immune health supplements market is divided by Ingredient type into Vitamins, Minerals, probiotics, Amino acids, Omega 3-fatty acids, and others. Among these Vitamins and Minerals held the largest share in the year 2020. The domination of vitamins and minerals in a plant-based health supplement contributes significantly to the segment's growth. The influence of COVID-19 has increased demand for vitamin C in the form of candies and chewable made from elderberry, cranberry, and other fruits, causing the market to expand even faster. The growing demand for plant-based Omega 3, the availability of herbal doses in powder and liquid forms, and the relevance of vegan claims in immune supplements are all elements that might propel the industry forward in the future years.
Hypermarkets and Supermarkets to grow with the highest CAGR during 2020-30
Under distribution, channel category Hypermarkets/ Supermarkets are held the largest share in 2020. In 2020, the supermarkets and hypermarkets category dominated, and this trend is projected to continue during the projection period. Immune health supplements are purchased from convenience stores in markets such as India, Indonesia, and Brazil, which contributes to the overall income creation.
Market Dynamics
Drivers
Increasing number of chronic cases
The overall immune health market is expected to develop at a significant rate due to the rising demand for health supplements to boost immunity. Additionally, the growing incidence of chronic illnesses throughout the world is a significant driver of market development during the projection period. The need for immune health supplements is likely to rise as the world's lifestyle disorders change.
Innovation & Formulation of Novel Immune Supplements
The rise of the dietary supplement market, as well as the expansion of commercial prospects for producers, has been fueled by innovation. Consumers are also being influenced to test these new revolutionary supplements by the introduction of new products with greater health advantages. In addition, the increased usage of novel and conventional components in supplement production is a significant role in the development of new creative dietary supplements.
Restraint
Lack of awareness about the immune healthy supplement
During the projected period, the lack of awareness about immune health supplements in various developing nations is expected to provide a challenge to the market expansion of immune health supplements.
Global Immune Health Supplements Market: Key Players
Alticor, Inc.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Bayer AG
Biotech Pharmacal, Inc.
Cellderm Technologies Inc.
DuPont Nutrition & Health
EuroPharma, Inc
Glanbia PLC
Kerry Group PLC
Koninklijke DSM NV
Now Foods
Nutramax Laboratories, Inc.
Nutrigold, Inc.
Seroyal USA LLC
Global Immune Health Supplements Market: Regions
Global Immune Health Supplements Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and Middle East, and Africa. Global Immune Health Supplements Market in North America held the largest market share in the year 2020. North America will continue to dominate the global Immune Health Supplements market owing to the region's well-developed healthcare system, along with the population's high disposable income. Additionally, increasing the paints and coating and pharmaceuticals industry in the region is the major factor propelling the market growth. Moreover, the rising aging population and increasing incidence of chronic diseases is anticipated to support the market.
Global Immune Health Supplements Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Russia, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Saudi Arabia, GCC, South Africa, and Rest of MENA
Global Immune Health Supplements Market report also contains analysis on:
Immune Health Supplements Segments:
By Ingredient type
Vitamins
Minerals
Herbal Botanical Extracts
Probiotics
Amino Acids
Omega 3-fatty acids
Others
By Form
Soft gels/ Capsules
Tablets
Powder
Liquids
Others
By Source Type
Plant-based
Animal-based
By Distribution Channel
Pharmacies and drug stores
Hypermarket/ Supermarket
Online stores
Specialty store
Others
Immune Health Supplements Market Dynamics
Immune Health Supplements Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Immune Health Supplements Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2020 USD 16.24 billion
Revenue forecast in 2030 USD 30.93 billion
Growth Rate CAGR of 6.65% from 2021 to 2030
Base year for estimation 2020
Quantitative units Revenue in USD billion and CAGR from 2021 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Ingredient type, Form, Source type, Distribution channel
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled Alticor, Inc., Bayer AG, Biotech Pharmacal Inc., Cellderm, Technologies Inc., DuPont Nutrition & Health, EuroPharma Inc, Glanbia PLC, Kerry Group PLC, Koninklijke DSM NV, Now Foods, Nutramax Laboratories, Inc., Nutrigold Inc., Seroyal USA LLC Other Prominent Players.
Frequently Asked Questions
How big is the Immune Health Supplements (EHR) market?
What is the Immune Health Supplements (EHR) market growth?
Which segment accounted for the largest Immune Health Supplements (EHR) market share?
Who are the key players in the Immune Health Supplements (EHR) market?
What are the factors driving the Immune Health Supplements (EHR) market?
As customers grow more worried about their health, immunity care has become an important element of today's hectic lifestyle. Nutritional supplements are used by today's time-conscious customers, even those who maintain healthy, balanced diets. Consumers all around the globe are feeling the need to strengthen their immune systems to prevent the negative consequences of infectious illnesses. Immune health supplements are essential for managing chronic diseases including diabetes, obesity, constipation, malabsorption, and indigestion. It also aids in the maintenance of a healthy lifestyle, the improvement of appetite and food intake, and the reduction of the danger of vitamin deficiencies and other health problems. Immune health supplements are advised for patients of all ages, including babies, adults, and geriatrics, who are at risk for diabetes, obesity, renal failure, chronic diseases, neurological diseases, and other illnesses.
Market Highlights
Global Immune Health Supplements Market is expected to project a notable CAGR of 6.65% in 2030.
Global Immune Health Supplements Market to surpass USD 30.93 billion by 2030 from USD 16.24 billion in 2020 at a CAGR of 6.65% in the coming years, i.e., 2020-30. The market is estimated to proliferate owing to the increasing awareness related to health matters, wellness trends, and changing routines. In addition, increasing trend of customized products based on health claims is predicted to fuel the growth of the market. Furthermore, the need for immunity-based health supplements is increasing as the population ages, in order to prevent or treat existing illnesses.
Recent highlights in the Global Immune Health Supplements Market
In February 2019, Swisse, Australian health, and wellness company has introduced Vitamin C+Manuka honey chewing tablets. Lemon and acerola cherry extracts are also included in the formula, which helps to boost the immune system.
In April 2020, Glycom, a major provider of Human Milk Oligosaccharides, has been acquired by Royal DSM, a global science-based corporation in nutrition, health, and sustainable living (HMOs). DSM aims to maintain its leadership in the early life nutrition and dietary supplement market with the help of this purchase.
Global Immune Health Supplements Market: Segments
Vitamins and minerals segment to grow with the highest CAGR during 2020-30
Global Immune health supplements market is divided by Ingredient type into Vitamins, Minerals, probiotics, Amino acids, Omega 3-fatty acids, and others. Among these Vitamins and Minerals held the largest share in the year 2020. The domination of vitamins and minerals in a plant-based health supplement contributes significantly to the segment's growth. The influence of COVID-19 has increased demand for vitamin C in the form of candies and chewable made from elderberry, cranberry, and other fruits, causing the market to expand even faster. The growing demand for plant-based Omega 3, the availability of herbal doses in powder and liquid forms, and the relevance of vegan claims in immune supplements are all elements that might propel the industry forward in the future years.
Hypermarkets and Supermarkets to grow with the highest CAGR during 2020-30
Under distribution, channel category Hypermarkets/ Supermarkets are held the largest share in 2020. In 2020, the supermarkets and hypermarkets category dominated, and this trend is projected to continue during the projection period. Immune health supplements are purchased from convenience stores in markets such as India, Indonesia, and Brazil, which contributes to the overall income creation.
Market Dynamics
Drivers
Increasing number of chronic cases
The overall immune health market is expected to develop at a significant rate due to the rising demand for health supplements to boost immunity. Additionally, the growing incidence of chronic illnesses throughout the world is a significant driver of market development during the projection period. The need for immune health supplements is likely to rise as the world's lifestyle disorders change.
Innovation & Formulation of Novel Immune Supplements
The rise of the dietary supplement market, as well as the expansion of commercial prospects for producers, has been fueled by innovation. Consumers are also being influenced to test these new revolutionary supplements by the introduction of new products with greater health advantages. In addition, the increased usage of novel and conventional components in supplement production is a significant role in the development of new creative dietary supplements.
Restraint
Lack of awareness about the immune healthy supplement
During the projected period, the lack of awareness about immune health supplements in various developing nations is expected to provide a challenge to the market expansion of immune health supplements.
Global Immune Health Supplements Market: Key Players
Alticor, Inc.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Bayer AG
Biotech Pharmacal, Inc.
Cellderm Technologies Inc.
DuPont Nutrition & Health
EuroPharma, Inc
Glanbia PLC
Kerry Group PLC
Koninklijke DSM NV
Now Foods
Nutramax Laboratories, Inc.
Nutrigold, Inc.
Seroyal USA LLC
Global Immune Health Supplements Market: Regions
Global Immune Health Supplements Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and Middle East, and Africa. Global Immune Health Supplements Market in North America held the largest market share in the year 2020. North America will continue to dominate the global Immune Health Supplements market owing to the region's well-developed healthcare system, along with the population's high disposable income. Additionally, increasing the paints and coating and pharmaceuticals industry in the region is the major factor propelling the market growth. Moreover, the rising aging population and increasing incidence of chronic diseases is anticipated to support the market.
Global Immune Health Supplements Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Russia, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Saudi Arabia, GCC, South Africa, and Rest of MENA
Global Immune Health Supplements Market report also contains analysis on:
Immune Health Supplements Segments:
By Ingredient type
Vitamins
Minerals
Herbal Botanical Extracts
Probiotics
Amino Acids
Omega 3-fatty acids
Others
By Form
Soft gels/ Capsules
Tablets
Powder
Liquids
Others
By Source Type
Plant-based
Animal-based
By Distribution Channel
Pharmacies and drug stores
Hypermarket/ Supermarket
Online stores
Specialty store
Others
Immune Health Supplements Market Dynamics
Immune Health Supplements Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Immune Health Supplements Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2020 USD 16.24 billion
Revenue forecast in 2030 USD 30.93 billion
Growth Rate CAGR of 6.65% from 2021 to 2030
Base year for estimation 2020
Quantitative units Revenue in USD billion and CAGR from 2021 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Ingredient type, Form, Source type, Distribution channel
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled Alticor, Inc., Bayer AG, Biotech Pharmacal Inc., Cellderm, Technologies Inc., DuPont Nutrition & Health, EuroPharma Inc, Glanbia PLC, Kerry Group PLC, Koninklijke DSM NV, Now Foods, Nutramax Laboratories, Inc., Nutrigold Inc., Seroyal USA LLC Other Prominent Players.
Frequently Asked Questions
How big is the Immune Health Supplements (EHR) market?
What is the Immune Health Supplements (EHR) market growth?
Which segment accounted for the largest Immune Health Supplements (EHR) market share?
Who are the key players in the Immune Health Supplements (EHR) market?
What are the factors driving the Immune Health Supplements (EHR) market?
1. EXECUTIVE SUMMARY
2. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa (Saudi Arabia, GCC, South Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Ingredient Type: Market Share (2020-2030F)
12.2.1. Vitamins, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Minerals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Herbal Botanical Extracts, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Probiotics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.5. Amino Acids, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.6. Omega 3-fatty acids, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.7. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Form: Market Share (2020-2030F)
12.3.1. Soft gels/ Capsules, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Tablets, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Powder, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Liquid, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Source Type: Market Share (2020-2030F)
12.4.1. Plant-based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Animal-based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By Distribution Channel: Market Share (2020-2030F)
12.5.1. Pharmacies and drug stores, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Hypermarket/ Supermarket, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Online stores, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Specialty store, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Alticor, Inc.
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Bayer AG
13.3. Biotech Pharmacal, Inc.
13.4. Cellderm Technologies Inc.
13.5. DuPont Nutrition & Health
13.6. EuroPharma, Inc
13.7. Glanbia PLC
13.8. Kerry Group PLC
13.9. Koninklijke DSM NV
13.10. Now Foods
13.11. Nutramax Laboratories, Inc.
13.12. Nutrigold, Inc.
13.13. Seroyal USA LLC
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa (Saudi Arabia, GCC, South Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Ingredient Type: Market Share (2020-2030F)
12.2.1. Vitamins, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Minerals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Herbal Botanical Extracts, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Probiotics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.5. Amino Acids, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.6. Omega 3-fatty acids, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.7. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Form: Market Share (2020-2030F)
12.3.1. Soft gels/ Capsules, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Tablets, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Powder, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Liquid, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Source Type: Market Share (2020-2030F)
12.4.1. Plant-based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Animal-based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By Distribution Channel: Market Share (2020-2030F)
12.5.1. Pharmacies and drug stores, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Hypermarket/ Supermarket, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Online stores, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Specialty store, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Alticor, Inc.
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Bayer AG
13.3. Biotech Pharmacal, Inc.
13.4. Cellderm Technologies Inc.
13.5. DuPont Nutrition & Health
13.6. EuroPharma, Inc
13.7. Glanbia PLC
13.8. Kerry Group PLC
13.9. Koninklijke DSM NV
13.10. Now Foods
13.11. Nutramax Laboratories, Inc.
13.12. Nutrigold, Inc.
13.13. Seroyal USA LLC
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
